Vida Recoletas Sevilla
20
2
2
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
35.0%
7 terminated/withdrawn out of 20 trials
58.8%
-27.7% vs industry average
5%
1 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
Detection of Kisspeptins and miRNAs in Patients With Non-viable Pregnancy
Role: lead
Triggering Ovulation at Follicle Size Smaller or Larger Than 17mm in a Modified Natural Cycle
Role: lead
CENP-V As a Potential Diagnostic Marker of Damage in Human Oocytes
Role: lead
Capacitation-associated Protein Tyrosine Phosphorylation As a Possible Biomarker of Sperm Selection
Role: lead
Sperm Separation Efficiency to Maximize Pregnancy Rates: MACS vs. FERTILE Chip
Role: lead
Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer
Role: collaborator
Psychosocial Intervention in Assisted Reproduction Treatments
Role: lead
Embryo Implantation After Induced Endometrial Injury
Role: collaborator
Day 3 Embryo Biopsy Versus Blastocyst Biopsy in PGS Cases
Role: lead
Tachykinin and Kisspeptin Expression in Human Granulosa and Cumulus Cells
Role: lead
Evaluation of a Closed Assisted Reproductive Technology (ART) Station Versus an Open Flow Cabinet
Role: lead
Ultrasound Study by Texturization as a Predictor of Pregnancy in Oocyte Donation Programs
Role: lead
Magnetic Activated Cell Sorting in Artificial Insemination With Donor Sperm
Role: lead
Application of MACS and Time-lapse Technology in Good-prognosis Patients
Role: lead
Impact of Human Embryo Culture System on Live Birth
Role: lead
Valuation of Variable Dose of Docosahexanoic Acid for the Improvement of the Parameters of Male Fertility
Role: lead
Physiological Role of KiSS-1/GPR54 System in the Human Ovary
Role: lead
Single Embryo Transfer Versus Double Embryo Transfer
Role: lead
Corifollitropin Alfa Versus Daily rFSH in the Controlled Ovarian Stimulation of Poor Responders
Role: lead
IUI Schedule in Cases of High Progesterone
Role: collaborator
All 20 trials loaded